United States hip replacement devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing demands for the hip replacement surgeries. Rising geriatric population of the country and rising prevalence of lower extremity conditions such as Osteoarthritis (OA), osteoporosis and hip ailments are some of the major factors driving the growth of the United States hip replacement devices market in the upcoming five years. Consistent research and technological advancement in the medical devices further support the growth of the United States hip replacement devices market in the next five years.
Hip replacement surgeries are the medical procedures where diseases or damaged parts of the hip joints and installs an implant. The devices utilized for the surgical process of hip replacement are categorized as hip replacement devices and are further classified under primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. Incidences of accidents, stair falls, and sports events often leads to fracture of dislocation of the hip joints, other than the diseases.
Orthopedic Surgeries Drive Market Growth
Rising instances of the orthopedic surgeries majorly on the hip region, is actively driving the growth of the United States hip replacement devices market in the upcoming five years. Advancing healthcare services and patient care adds to the surgical approaches toward hip replacement procedures. Also, growing cases of implants, and corrective devices that aids the orthopedic structure of the body, further supports the growth of the United States hip replacement devices market in the next five years.
Increasing surgical ventures, demand higher count of expert surgeons functioning in the country. The healthcare system in the country provides well for the experts and the number of the healthcare experts & workers have been rising rapidly in the recent years, thus aiding market growth. In the year 2021, there were 22,965 orthopedic surgeons in the country. More than 450,000 hip replacement surgeries are performed every year in the United States. Also, growing instances of diseases like osteoarthritis, rheumatoid arthritis, post traumatic arthritis, osteonecrosis, childhood arthritis in hips, etc. leads the market growth by aiding the demands for hip replacement surgeries.
Investments & Advancement Support Market Growth
The healthcare industry is well established in the United States. In fact, it is one of the world’s best healthcare hub that provides excellent healthcare services and patient care. Technologically advanced medical devices, high tech healthcare infrastructure, and advanced medicine adds to the potential growth of the industry along with the market. Higher expenses over healthcare services & patient care from the government as well as the consumers, substantiates the growth of the United States hip replacement devices market in the upcoming five years.
Click here to download the sample
Market Segmentation
The United States hip replacement devices market is segmented by product type, end user, competitional landscape, and regional distribution.
Company Profile
Johnson & Johnson (DePuy Synthes), B. Braun Medical, Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Exactech, Inc., Conformis Inc., OMNIlife Science Inc., DJO Global, Inc., Medtronic USA, Inc., Aesculap Implant Systems, Inc.
| Attribute | Details |
| Base Year | 2021 |
| Historical Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | |
| Regional scope | South region, Mid-West region, North-East region, and West region. |
| Key companies profiled | Johnson & Johnson (DePuy Synthes), B. Braun Medical, Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Exactech, Inc., Conformis Inc., OMNIlife Science Inc., DJO Global, Inc., Medtronic USA, Inc., Aesculap Implant Systems, Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
